A method for treating 
asthma in a subject includes inserting a therapy delivery device into a vessel of a subject. The therapy delivery device is advanced to a point substantially adjacent an intraluminal 
target site of the 
autonomic nervous system. Next, the therapy delivery device is activated to deliver a therapy 
signal to the intraluminal 
target site to treat the 
asthma. The intraluminal 
target site is in electrical communication with 
nervous tissue selected from the group consisting of a 
spinal nerve, pre- or post-ganglionic autonomic fibers, a sympathetic chain 
ganglion, a thoracic sympathetic chain 
ganglion, a cervical 
ganglion, a lower cervical ganglion, an inferior cervical ganglion, an intramural ganglion, a splanchnic nerve, an esophageal 
plexus, a cardiac 
plexus, a pulmonary 
plexus, an anterior pulmonary plexus, a posterior pulmonary plexus, a celiac plexus, a hypogastric plexus, an inferior mesenteric ganglion, a celiac ganglion, and a superior mesenteric ganglion.